Forte Biosciences, Inc. (FBRX)
28.76
-1.52
(-5.02%)
USD |
NASDAQ |
Mar 06, 16:00
28.77
+0.01
(+0.03%)
After-Hours: 20:00
Forte Biosciences EPS Diluted (Quarterly) : -0.9937 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.68M |
| Total Expenses (Quarterly) | 17.68M |
| Enterprise Value | 266.86M |
| Earnings Yield | -15.45% |
| Normalized Earnings Yield | -15.45 |